Blocking the frontline immune response could improve vaccines against viral diseases such as coronaviruses, according to a Northwestern Medicine study.
A new combination therapy targeting breast cancer tumors in the brain dramatically decreased tumor size and increased survival in mice, according to a new study.
A novel deep brain stimulation device significantly improved quality of life for patients with advanced Parkinson’s disease while also reducing common physical side effects from medication, according to findings published in The Lancet Neurology.
Targeting oxidative stress with a genetic therapy reduced atrial fibrillation in animal models of disease, making this a promising future treatment, according to a study published in Circulation.
Genomic alterations in prostate cancer therapeutic targets were found to be similar between African American and European American men, suggesting that existing precision medicine approaches could equally benefit both groups if applied equitably, according to a recent study.
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.
A drug commonly used to reduce serum urate levels proved ineffective in slowing disease progression in patients with diabetic kidney disease, according to a recent study.
A Northwestern Medicine study found that inducing inflammation in lung epithelial cells contributes to the development of chronic obstructive pulmonary disease.
Deaths due to heart failure and hypertensive heart disease are increasing in the U.S. — particularly in Black women and men — despite medical and surgical advances in heart disease management, according to a new Northwestern Medicine study.